Trupanion (NASDAQ:TRUP) Given New $57.00 Price Target at Piper Sandler

Trupanion (NASDAQ:TRUP) had its price target raised by analysts at Piper Sandler from $45.00 to $57.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the financial services provider’s stock. Piper Sandler’s price objective indicates a potential upside of 3.28% from the stock’s current price.

Several other research firms also recently weighed in on TRUP. Bank of America lifted their target price on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research report on Friday, September 20th. Northland Securities boosted their price objective on Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research report on Thursday, September 19th. William Blair started coverage on Trupanion in a research report on Friday, July 19th. They set an “outperform” rating for the company. Evercore ISI raised Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Finally, Stifel Nicolaus boosted their price objective on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research report on Monday, September 23rd. Four research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $43.83.

Trupanion Trading Up 0.1 %

NASDAQ TRUP traded up $0.07 during trading on Thursday, hitting $55.19. The stock had a trading volume of 520,462 shares, compared to its average volume of 679,287. The company has a market capitalization of $2.32 billion, a PE ratio of -86.56 and a beta of 1.73. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. The firm has a 50 day moving average price of $46.73 and a 200 day moving average price of $35.87. Trupanion has a twelve month low of $19.14 and a twelve month high of $57.90.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.09. The company had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. Trupanion’s revenue was up 14.6% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.10) EPS. As a group, equities research analysts forecast that Trupanion will post -0.34 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares in the company, valued at approximately $4,647,256.32. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Fawwad Qureshi sold 624 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. Insiders sold a total of 8,764 shares of company stock worth $405,238 over the last 90 days. 5.50% of the stock is owned by insiders.

Institutional Investors Weigh In On Trupanion

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. GAMMA Investing LLC increased its holdings in shares of Trupanion by 70.4% in the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after purchasing an additional 596 shares during the period. Headlands Technologies LLC acquired a new position in shares of Trupanion in the second quarter valued at approximately $162,000. Oppenheimer Asset Management Inc. acquired a new position in shares of Trupanion in the second quarter valued at approximately $235,000. Handelsbanken Fonder AB acquired a new position in shares of Trupanion in the third quarter valued at approximately $248,000. Finally, Bayesian Capital Management LP acquired a new position in shares of Trupanion in the first quarter valued at approximately $253,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.